Newsfeeds - Spark Newswire

2 minute read

Why PacWest Bancorp Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket

Today, 4:53 PM

Gainers PacWest Bancorp (NASDAQ: PACW) rose 29.9% to $12.66 in pre-market trading after multiple insider buys by Officers, Directors reported late Monday.

AMLX

4 minute read

Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 4:53 PM

Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.

ARDS

2 minute read

5 Short Squeeze Candidates To Watch: Ambrx Biopharma, Kala Pharmaceuticals And This Company That Moved Up 1,403 Positions

By Chris Katje

Today, 4:53 PM

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.

AMAM

1 minute read

Cingulate Q4 EPS $(0.41) Misses $(0.37) Estimate

By Michael Horton

Today, 4:53 PM

Cingulate (NASDAQ:CING) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.37) by 10.81 percent. This is a 28.12 percent decrease over losses of $(0.32) per share from the

CING

2 minute read

Tesla, Amazon, Union Pacific, Woodside Energy, Cingulate: Why These 5 Stocks Drawing Investors’ Attention Today

By Bhavik Nair

Today, 4:53 PM

Major Wall Street indices closed over 1% lower on Friday as the core personal consumption expenditures price index,…

AMZN

3 minute read

Dow Dips 350 Points; S&P 500 Down Over 1%

By Lisa Levin

Today, 4:53 PM

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Friday. The Dow traded down 1.07% to 32,798.91 while the NASDAQ fell 1.90% to 11,370.53. The S&P 500 also fell, dropping, 1.23% to 3,963.05

BAER

1 minute read

Why Cingulate Shares Are Trading Higher Today

By Vandana Singh

Today, 4:53 PM

Cingulate Inc (NASDAQ:CING) announced positive topline results from the CTx-1301-003 study assessing the effect of food on the absorption of its…

CING

22 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For January 17, 2023

By Benzinga Insights

Today, 4:53 PM

Upgrades For Casa Systems Inc (NASDAQ:CASA), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform.…

1 minute read

HC Wainwright & Co. Initiates Coverage On Cingulate with Buy Rating, Announces Price Target of $5.5

By Benzinga Newsdesk

Today, 4:53 PM

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Cingulate (NASDAQ:CING) with a Buy rating and announces Price Target of $5.5.

CING

1 minute read

Cingulate Kickstarts First Phase 3 Trial For ADHD Candidate, Data Expected In First Half 2023

By Vandana Singh

Today, 4:53 PM

Cingulate Inc (NASDAQ: CING) has initiated the first Phase 3 clinical trial of its lead candidate CTx-1301, an extended-release tablet formulation of dexmethylphenidate, a compound approved by the FDA for attention-deficit/hyperactivity disorder (ADHD).

CING